Linda Humbert,Emmanuelle Proust-Lemoine,Sylvain Dubucquoi,Elisabeth Helen Kemp,Pascale Saugier-Veber,Nicole Fabien,Isabelle Raymond-Top,Catherine Cardot-Bauters,Jean-Claude Carel,Maryse Cartigny,Olivier Chabre,Philippe Chanson,Brigitte Delemer,Christine Do Cao,Laurence Guignat,Jean Emmanuel Kahn,Veronique Kerlan,Herve Lefebvre,Agnès Linglart,Roberto Mallone,Rachel Reynaud,Boualem Sendid,Pierre-François Souchon,Philippe Touraine,Jean-Louis Wémeau,Marie-Christine Vantyghem

Abstract:Abstract Background Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC) and nonendocrine manifestations. The aim of this study was to determine the molecular profile of the AIRE gene, the prevalence of rare manifestations, and to characterize immunological disturbances in a French cohort. Patients and Methods A national, multicenter prospective observational study to collect genetic, clinical, biological, and immunological data (NCT03751683). Results Twenty-five patients (23 families) were enrolled. Eleven distinct AIRE variants were identified, 2 of which were not previously reported: an intronic variant, c.653-70G > A, and a c.1066del (p.Arg356GlyfsX22) variant (exon 9). The most common was the Finnish variant c.769C > T (16 alleles), followed by the variant c.967_979del13 (15 alleles), which seemed associated with a less severe phenotype. Seventeen out of 25 patients were homozygote. The median number of clinical manifestations was 7; 19/25 patients presented with the hypoparathyroidism-adrenal failure-CMC triad, 8/13 showed pulmonary involvement, 20/25 had ectodermal dystrophy, 8/25 had malabsorption, and 6/23 had asplenia. Fifteen out of 19 patients had natural killer cell lymphopenia with an increase in CD4+ and CD8+ T lymphocytes and an age-dependent alteration of B lymphocyte homeostasis compared with matched controls (P < .001), related to the severity of the disease. All tested sera (n = 18) were positive for anti-interferon-α, 15/18 for anti-IL-22 antibodies, and 13/18 for anti-IL-17F antibodies, without clear phenotypic correlation other than with CMC. Conclusion This first prospective cohort showed a high AIRE genotype variability, with 2 new gene variants. The prevalence of potentially life-threatening nonendocrine manifestations was higher with systematic screening. These manifestations could, along with age-dependent B-cell lymphopenia, contribute to disease severity. Systematic screening for all the manifestations of the syndrome would allow earlier diagnosis, supporting vaccination and targeted therapeutic approaches.

AIRE deficiency, from preclinical models to human APECED disease

Where AIRE we now? Where AIRE we going?

Lessons From Prospective Longitudinal Follow-up of a French APECED Cohort

A deep intronic splice–altering AIRE variant causes APECED syndrome through antisense oligonucleotide-targetable pseudoexon inclusion

A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1

Autoimmune Regulator (aire) Deficiency Results in Reduced Memory CD8+ T Cells after Listeria Monocytogenes Infection in a Murine Model.

Aire‐ing Self Antigen Variability and Tolerance

AIRE functions as an E3 ubiquitin ligase.

AIRE Gene Mutation Presenting at Age 2 Years With Autoimmune Retinopathy and Steroid-Responsive Acute Liver Failure: A Case Report and Literature Review

A Specific Anti-Aire Antibody Reveals Aire Expression is Restricted to Medullary Thymic Epithelial Cells and Not Expressed in Periphery.

Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice.

High-Resolution Transcriptional Impact of AIRE: Effects of Pathogenic Variants p.Arg257Ter, p.Cys311Tyr, and Polygenic Risk Variant p.Arg471Cys

Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein

Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation

Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review

Autoimmune Regulator (AIRE) Deficiency Does Not Affect Atherosclerosis and CD4 T Cell Immune Tolerance to Apolipoprotein B

Aire and T cell development

The susceptibility of Aire−/− mice to experimental myasthenia gravis involves alterations in regulatory T cells

Tracking the role of Aire in immune tolerance to the eye with a TCR transgenic mouse model

Twenty Years of AIRE

A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1